Reuters logo
BRIEF-Transgene presents clinical data on TG1050 regarding chronic hepatitis B​
October 17, 2017 / 4:23 PM / a month ago

BRIEF-Transgene presents clinical data on TG1050 regarding chronic hepatitis B​

Oct 17 (Reuters) - TRANSGENE SA:

* ‍TRANSGENE PRESENTS FIRST CLINICAL DATA INDICATING THAT TG1050 INDUCES A ROBUST AND HBV-SPECIFIC CELL-MEDIATED IMMUNE RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS B​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below